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SUMMARY
Background. Conducting a pragmatic randomised trial in
primary care is often accompanied by practical problems.
Such problems are seldom reported and may constitute
useful lessons for researchers planning future trials.
Aim. To address the difficulties involved in patient recruit-
ment and to present measures to minimise bias during out-
come assessment. 
Method. A recently conducted trial comparing the effects of
corticosteroid injections and physiotherapy for painful stiff
shoulder was used to illustrate problems related to patient
recruitment and outcome assessment. 
Results. Recruitment of patients was not without difficulties
despite careful preparation. Recruitment was discontinued
after 20 months, when 109 of the intended 120 patients had
been admitted to the trial. The shoulder trial mainly included
patient-oriented subjective outcome measures. Subgroup
analyses demonstrated that patient preferences might have
had some influence on outcome. 
Conclusions. General practitioners might be willing or
unwilling to participate in research for many reasons. The
researcher should take these motivations into account when
inviting physicians to take part in research. Strategies to
enhance enrolment should be prepared before the start of
the trial. When blinding of patients is problematic, patient
preferences should be assessed before randomisation and
their influence on the outcome studied. Although involving a
blinded independent observer enables a more objective
assessment of outcome, the success of blinding should be
clearly evaluated.
Keywords: patient recruitment; research; randomised trial;
shoulder pain.
Introduction
EFFECTIVE patient recruitment is a prerequisite for the suc-cessful completion of any randomised clinical trial. Before
the start of a trial researchers are often overly optimistic regard-
ing the number of available and eligible patients but recruitment
usually falls short of expectations once the trial has started. This
phenomenon has been described as Lasagna’s Law.1,2 When
determining the required sample size and designing recruitment
procedures, several factors should be taken into consideration,
including the (lack of) appeal the trial may have for eligible
patients, the relatively strict inclusion criteria, and the limited
time or motivation of recruiting physicians. Trials may even have
to be suspended or prematurely ended owing to unsuccessful
recruitment.3 The first objective of this paper was to address the
difficulties involved in patient recruitment when conducting a
randomised trial in primary care. Such difficulties are seldom
reported but may constitute useful lessons for researchers plan-
ning future trials.
This paper focuses on the design and execution of pragmatic
trials4 only. Pragmatic trials compare the effects of interventions
as they are being carried out in everyday clinical care. Placebo
interventions are typically not included in the design, which lim-
its the potentials for blinding. Inadequate blinding has been
demonstrated to be associated with an increased risk of bias.5
Therefore, the second objective of this paper was to present mea-
sures that can be taken to minimise bias in the outcome assess-
ment of pragmatic trials and to evaluate the influence of potential
sources of bias on the results of a trial. 
Method
In January 1995, data collection was started for a randomised
trial in Dutch primary care, comparing the effects of corticos-
teroid injections and physiotherapy for painful stiff shoulder.6
Although the study has been completed successfully, a number
of difficulties had to be overcome during data collection.
Patient recruitment
The intended study population was 120 patients. Sample-size
calculations showed that approximately 60 patients in each inter-
vention group would be needed to detect a difference in success
rate of 25%, which was assumed to be clinically relevant.
Patients who consulted their general practitioner (GP) for a
painful stiff shoulder were considered for participation. The main
selection criteria were painful restriction of the passive range of
motion; unilateral symptoms; no treatment of the shoulder with
injections or physiotherapy during the previous six months; and
informed consent. Final selection was carried out at a research
centre by an independent observer (trained physiotherapist). 
The shoulder trial was preceded by an observational study on
shoulder disorders.7,8 The results of this study enabled an estima-
tion of the availability of eligible patients for the trial. New
episodes of shoulder pain were recorded during a one-year period
by 18 GPs. The incidence of shoulder disorders was estimated at
11.2/1000 registered patients per year,7 which was comparable to
the results of a national survey (12.8/1000).9 The diagnosis
‘painful stiff shoulder’ (capsular syndrome or capsulitis) was
made in 21% of all incident cases, implying that, on average,
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about four new eligible cases are encountered each year. Sixty-
one GPs agreed to participate in the trial. Allowing for patient
refusals and dropouts owing to exclusion criteria, we estimated
that the intended study population of 120 patients would be within
easy reach, as 18 months were available for patient recruitment.
Outcome assessment
Participants were randomly allocated to either injection therapy
(intra-articular corticosteroids) administered by the GP or six
weeks of physiotherapy. Outcomes and adverse effects were
assessed at three and seven weeks. Long-term follow-up assess-
ments were scheduled at three, six, and 12 months after randomi-
sation. The main outcome measures were general improvement
according to the patient, severity of the main complaint, pain,
and functional disability. 
The patients in the shoulder trial could not be blinded for the
allocated intervention. A preference for one of the interventions
under study could influence their response to treatment and their
scores on subjective outcome measures. If many patients indicate
a preference and the preferences are unequally distributed among
intervention groups there is an increased risk of obtaining a
biased estimate of outcome. Therefore, before randomisation all
patients were asked to state any preferences. After the conclusion
of data collection their influence on the results of the trial was
evaluated in exploratory subgroup analyses. 
In order to enable a partly-blinded assessment of outcome, the
independent observer, who measured range of motion and gave a
judgement of the overall severity of the disorder, was not
informed about the allocated treatment. Before each follow-up
examination, the patients were instructed by a research assistant
not to mention their allocated treatment. Furthermore, the (poten-
tial) injection site was covered with gauze in each patient. In
order to evaluate the success of blinding, the independent observ-
er was asked to guess the allocated treatment after each examina-
tion and to state reasons for any assumptions.
Results
Patient recruitment
A total of 203 patients were referred to the research centres but
94 could not be admitted to the trial. In most cases the diagnosis
could not be confirmed by the independent observer (n = 73).
Findings from our observational study had indeed indicated that,
in many cases, the diagnosis of shoulder pain was not unequivo-
cal. Inter-observer agreement between GPs and physiotherapists
was only fair (K= 0.31).10 Nevertheless, exclusion for this reason
was more frequent than we had anticipated. The GPs were also
asked to refer patients for whom they were uncertain about the
diagnosis. This probably increased the sensitivity of our search
for eligible patients but simultaneously decreased its specificity.
Recruitment was discontinued after 20 months, when 109
patients had been admitted to the trial. 
All participants were enrolled by 40 of the 61 GPs (Table 1).
Eleven GPs recruited at least four participants each, together
enrolling more than half of the study population (57 patients).
There were more male physicians than female among the more
successful recruiters but it was a female practitioner who recruit-
ed the largest number of participants (n = 12). The proportion of
referrals that were actually enrolled in the trial was more or less
similar for most GPs (60% to 67%), which may indicate that the
majority of GPs were not discouraged by exclusion of patients by
the independent observer. Other variables, such as the size or
location of the practice, did not appear to have a large influence
on recruitment rate. 
When asked, the GPs indicated that the main reasons for not
referring eligible patients to the research centre were busy
surgery hours, forgetfulness, or the conviction that a patient
would benefit more from a specific intervention. Several mea-
sures were taken to encourage participation. Monthly newsletters
were distributed, reminders were sent, and practices were visited
at six-month intervals. Any questions regarding trial procedures
received prompt and adequate feedback, implying easy accessi-
bility during office hours. When a patient was excluded from the
trial, the GP received a copy of the results of the examination at
the research centre, including reasons for exclusion. The flexibil-
ity of trial procedures was increased by assessing patients at
home if they were unable to visit the research centre or by
enabling assessments after office hours. 
After an extension of the recruitment period of two months,
we decided to settle for a slightly smaller study size. As the
dropout rate was very low, there was very little compromise of
the statistical power because of this decision.
Outcome assessment 
The results of subgroup analyses on patient preferences seem to
i dicate that being allocated to the preferred intervention had
some influence on success rate but only for patients allocated to
injection therapy (Table 2). Success rate (complete recovery or
considerable improvement) was 85% for patients who received
their preferred intervention (injections), compared with an over-
all success rate of 77% and only 64% for those who had received
injections but preferred physiotherapy. It should be noted that the
number of patients in the subgroups is small, which has probably
resulted in unstable subgroup effects. 
Blinding of the independent observers was partially success-
ful. At the seven-week follow-up, the observers correctly guessed
the allocated intervention for 65 patients and incorrectly guessed
for 19 patients. For 24 patients the observers had no idea about
the allocated intervention. A ‘slip of the tongue’ by the patient or
one of the co-workers of the study was the reason for unmasking
in 13 cases. In most other patients the guess was based on the
clinical course of symptoms. A fast recovery, particularly from
pain, was often correctly ascribed to injection therapy. 
Discussion
Patient recruitment
Although a considerable number of GPs agreed to take part in
he shoulder trial, not all turned out to be effective and successful
recruiters. We are not sure about the main reasons for the diffi-
culties during recruitment but they could be manifold: busy
surgery hours may have interfered with selection of patients, trial
procedures may have been too restrictive, or maybe there was
simply a lack of eligible patients.
When GPs are asked to participate in patient recruitment,
attention should be paid to the many reasons why they might be
either willing or unwilling to participate in a trial (Box 1).2,3,11-13
The trial should address a relevant research question, the out-
come of which is applicable to general practice. It is of no use if
research questions are ‘merely the products of scientific advertis-
ing, however attractive’.3 A smooth organisation is important,
with adequate support from researchers, clear guidelines, and
short questionnaires that impose minimal demands on time. We
share the opinion of other authors that reimbursement should not
be used as a coercive tactic.2,3,14Nevertheless, a reasonable com-
pensation can be offered for the time invested during surgery
hours. Extra training or postgraduate education is often appreci-
ated, such as the instruction on the physical examination of the
shoulder joint and injection technique that preceded our trial.
Requesting informed consent can be difficult, as it may not be
easy to forsake the role of the confident prescriber and adopt the
attitude of the researcher who is uncertain about the most effec-
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tive treatment available.3 Taylor and Kelnor designed a question-
naire (Physician Orientation Profile) giving physicians a score
along the continuum of attitude towards treatment, ranging from
purely experimental to purely therapeutic.15 Although it will not
be necessary to use such a questionnaire, it may be worthwhile to
specifically aim for the participation of GPs who are interested in
research and are acquainted with research methods, rather than to
take a random sample or simply recruit as many practitioners as
possible.
A strategy for approaching primary care settings has been pro-
posed by Murphyet al.16 They recommend identifying all people
who may have an interest in the study (stakeholders), finding a
‘local champion’ to assist in approaching primary care settings
(care providers of some standing or influence in the community),
and supplying adequate, but concise, information. Half-hearted
or ill-informed consent may guarantee the successful start of a
trial but practitioners may soon withdraw once the implications
of participation become clear.
Even if many GPs have consented to participate, actual patient
recruitment may fall short of expectations. A prolonged and
laborious recruitment procedure may result in changes in the
implementation or interpretation of selection criteria, outcome
measures, and other procedures. A ‘rescue plan’ developed prior
to the trial, including a series of alternative strategies to increase
enrolment, will enable prompt actions to be taken.2 Measures to
enhance recruitment during a study may include enhancing the
motivation of all co-workers by writing newsletters, paying regu-
lar visits to the practice, providing consistent feedback, and
increasing the flexibility of trial procedures.14,17,18 Disagreeable
tests or questionnaires may be eliminated from the protocol.
Finally, researchers may decide to approach patients by advertis-
ing in the local media or weakening selection criteria. However,
as adjustment of selection criteria may result in the enrolment of
patients with a potentially different prognosis, it should not be
used without careful consideration.
Outcome assessment
Obtaining an unbiased estimate of outcome can be quite difficult
when different types of interventions are compared, and blinding
is difficult to implement. When subjective outcome measures are
used, patient preferences should be assessed before randomisa-
tion. Our results demonstrate that subgroup analyses can be help-
ful to determine whether the results of the trial are liable to be
influenced by preferences for one of the interventions under
study.
One way to prevent bias owing to patient preferences is to
include only ‘naïve’ patients19 — patients who have never been
treated with either intervention — or to include only those who
do not indicate a preference. We decided to allow participation
of patients with a preference, provided they were willing to take
the 50% risk of receiving the other treatment. Exclusion of all
patients indicating a preference would have resulted in an unac-
ceptable reduction in the number of eligible patients. 
Involving an independent observer can enable a more objec-
tive assessment of outcome. In this case the design of the trial
should incorporate methods to evaluate the success of blinding.
Frequent unmasking, or hypotheses made by the observers
regarding the expected results of the trial, may imply an
increased risk of bias. In the shoulder trial the blinding of inde-
pendent observers was partially successful. The observers appar-
ently had a presupposition about the results of the trial and their
hypothesis was confirmed in many cases. This does not necessar-
ily mean that outcome assessment was biased. The frequency of
unmasking was similar in both intervention groups. Furthermore,
the clues for guessing the assigned treatment were the results of
the follow-up examination, which might indicate that the assess-
ment of outcome measures (as part of the examination) was not
influenced. Rabkin et al20 have also shown that clinical outcome
can be the major predictor of accuracy in unmasking treatment
Table 1. Recruitment of patients by general practitioners (n = 61) for the shoulder trial.
Median number of Median number of Median proportion 
Success of recruitment n Male (%) referrals (range) patients enrolled (range) enrolled (range)
0 enrolled 21 67 0 (0–2) 0 0%
1–3 enrolled 29 79 3 (1–8) 2 (1–3) 60% (20–100)
x4 enrolled 11 91 7 (4–12) 4 (2–12) 67% (35–100)
Total 61 77 203 109 54%
Table 2. Overall success rates after seven weeks and for subgroups with and without a treatment preference.
Success rates (%) Group sizes (n)
Injections Physiotherapy Injections Physiotherapy
Overall 77 46 52a 56
No preference subgroup 80 47 25 34
Allocated to preferred intervention 85 43 13 14
Not allocated to preferred intervention 64 50 14 8
aOne withdrawal (refused injections).
• Relevant research question
• Interest in and knowledge of research methods
• Adequate support by researchers
• Minimal investment of time, the study does not disrupt everyday
practice, fool-proof organisation
• Adequate financial reimbursement
• Postgraduate training (credited)
• Not too much of a burden on the patient, no additional costs for the
patient
• No interference with patient–physician relationship
• No clear preference in favour of one of the interventions in the trial
• Not too much involvement in other studies
Box 1. Reasons why general practitioners may participate in a randomised
trial.
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allocation. They too believe that this may not necessarily harm
the internal validity of a trial, as long as assessment of clinical
status precedes the awareness of treatment condition. 
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